Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Liberty Health Sciences Inc.’s License Transfer Application Approved by the Florida Department of Health, Office of Medical Marijuana Use
TORONTO, Sept. 29, 2017 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCBB: LHSIF) (“Liberty” or the “Company”) today announced that the Florida Department of Health, Office of Medical Marijuana Use, approved the transfer of the license to cultivate, process and dispense medical marijuana in the State from Chestnut Hill Tree Farm LLC (“Chestnut”) to Liberty, effective September 28, 2017.
This approval, the first of its kind in the State of Florida, sees Liberty take over full ownership of Chestnut’s Medical Marijuana Treatment Center (“MMTC”) license, facility and operations. The change of ownership makes Liberty an officially licensed MMTC, with authorization to cultivate, process, and dispense medical marijuana in the State. Prior to obtaining the approval to transfer the license, Liberty was operating under a State-approved exclusive Management Agreement with Chestnut. With the approval, the Management Agreement dissolves.
We’re thrilled with the Florida Department of Health’s decision to approve the transfer of the license. We look forward to continuing to help patients in the State of Florida improve the quality of their lives. The agreements we’ve established with Aphria allow us to employ their industry leading and proven cultivation and processing techniques, while offering a full array of Aphria products to the citizens of Florida via home delivery and at our forthcoming Medical Cannabis Education Centers.
George Scorsis, CEO and Director of Liberty
Liberty’s previously announced Part II expansion plans for its Alachua, Florida facility remain on track. This expansion will increase Liberty’s annual medical cannabis production to 3,000 kgs by March 2018.
For more information on Aphria, please visit www.aphria.com
For more information on Liberty, please visit www.libertyhealthsciences.com
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. (“Liberty”) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
Original press release: http://www.newswire.ca/news-releases/liberty-health-sciences-incs-license-transfer-application-approved-by-the-florida-department-of-health-office-of-medical-marijuana-use-648626403.html
The most reliable, fact-based information on Liberty Health Sciences found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.